These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 31816300)
1. AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. Gawron AJ; Shah SC; Altayar O; Davitkov P; Morgan D; Turner K; Mustafa RA Gastroenterology; 2020 Feb; 158(3):705-731.e5. PubMed ID: 31816300 [No Abstract] [Full Text] [Related]
2. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gupta S; Li D; El Serag HB; Davitkov P; Altayar O; Sultan S; Falck-Ytter Y; Mustafa RA Gastroenterology; 2020 Feb; 158(3):693-702. PubMed ID: 31816298 [No Abstract] [Full Text] [Related]
3. Spotlight: Gastric Intestinal Metaplasia. Shah SC; Gupta S; Li D; Morgan D; Mustafa RA; Gawron AJ Gastroenterology; 2020 Feb; 158(3):704. PubMed ID: 32035529 [No Abstract] [Full Text] [Related]
4. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Altayar O; Davitkov P; Shah SC; Gawron AJ; Morgan DR; Turner K; Mustafa RA Gastroenterology; 2020 Feb; 158(3):732-744.e16. PubMed ID: 31816301 [No Abstract] [Full Text] [Related]
5. Gastric Intestinal Metaplasia (GIM): Clinical Decision Support Tool. American Gastroenterological Association Gastroenterology; 2020 Feb; 158(3):703. PubMed ID: 31948925 [No Abstract] [Full Text] [Related]
6. Gastric cancer prevention from the point of Helicobacter. Balaban YH; Simşek H; Tatar G Turk J Gastroenterol; 2014 Aug; 25(4):463-7. PubMed ID: 25254545 [No Abstract] [Full Text] [Related]
7. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions. Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252 [TBL] [Abstract][Full Text] [Related]
8. Risk of gastric cancer in children with Helicobacter pylori infection. Cam S Asian Pac J Cancer Prev; 2014; 15(22):9905-8. PubMed ID: 25520126 [TBL] [Abstract][Full Text] [Related]
9. Gastric intestinal metaplasia: subtypes and natural history. El-Zimaity HM; Ramchatesingh J; Saeed MA; Graham DY J Clin Pathol; 2001 Sep; 54(9):679-83. PubMed ID: 11533073 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy. Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693 [TBL] [Abstract][Full Text] [Related]
11. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655 [TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori-related precancerous lesions in Turkey: a retrospective endoscopic surveillance study. Bas B; Dinc B Croat Med J; 2020 Aug; 61(4):319-325. PubMed ID: 32881429 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxigenase-2 and osteopontin in gastric pre-neoplastic lesions in relation to H-pylori infection and grade of inflammation. Benedetti I; Hoyos J; Barrios L Rev Esp Patol; 2020; 53(2):79-87. PubMed ID: 32199598 [TBL] [Abstract][Full Text] [Related]
15. Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. Davitkov P; Altayar O; Shah SC; Gawron AJ; Mustafa RA; Sultan S; Morgan DR Gastroenterology; 2020 Feb; 158(3):751-759. PubMed ID: 31887260 [No Abstract] [Full Text] [Related]
16. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802 [TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. Liu KS; Wong IO; Leung WK World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668 [TBL] [Abstract][Full Text] [Related]
18. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions. Canzian F; Rizzato C; Obazee O; Stein A; Flores-Luna L; Camorlinga-Ponce M; Mendez-Tenorio A; Vivas J; Trujillo E; Jang H; Chen W; Kasamatsu E; Bravo MM; Torres J; Muñoz N; Kato I Int J Cancer; 2020 Nov; 147(9):2437-2445. PubMed ID: 32363734 [TBL] [Abstract][Full Text] [Related]
20. Intestinal metaplasia of the gastric cardia: a study from Turkey. Dinçer D; Besisik F; Sahin E; Demir K; Tuncer I; Cevikbas U; Mungan Z; Kaymakoglu S; Boztas G; Ozdil S; Cakaloglu Y; Okten A Hepatogastroenterology; 2002; 49(46):1153-6. PubMed ID: 12143225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]